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Significant progress has been made in recent years regarding the delineation of
the role of soluble mediators in hematopoiesis . Colony-stimulating factors have now
been described at a molecular level for most of the cells of the myeloid lineage (1),
and an ever increasing number of mediators are now known to regulate lympho-
cytes (2), the major effector cells ofthe immune response . Much less is known about
the molecular nature of the regulators that control development oflymphoid pro-
genitors . Recently we described the isolation and cloning of IL-7 (3, 4) . IL-7 was
originally detected and isolated on the basis of its potent proliferative effects on B
cell progenitors derived from long-term bone marrow cultures (3) . Interestingly, IL-
7 has now been shown to stimulate T cell progenitors (5-7) and is emerging as a
major element in the development of both B and T lymphocytes . In addition, it
is now clear that IL-7 can stimulate mature peripheral T cells (8, 9), and T cell
clones (10) ; however, the complete repertoire of cells responsive to IL-7 is still under
investigation .
In an effort to more clearly define the cells responsive to IL-7, we now describe
the initial characterization of the murine IL-7 receptor and the cellular distribution
of such receptors . We have developed a clonal cell line (IxN/2b) that is absolutely
dependent upon IL-7 for growth and viability and have used this cell line to define
the binding and structural characteristics of the murine IL-7 receptor. Additionally,
we have investigated the distribution of IL-7 receptors on an extensive library of
cell lines and primary tissues .
Materials and Methods
TheIxN/26 Cell Line and Bioassayfor IL-7
￿
This cell line was obtained by IL-7-dependent
limiting dilution cloning of the nonadherent cells from a long-term Whitlock-Witte bone
marrow culture as previously described (3) . These cells have now been in continuous culture
for more than 24 mo and have retained a strict growth dependence upon exogenous IL-7 .
The cells were routinely passaged by dilution to 2 x 10 4 cells/ml every 3 d in Iscove's modified
Dulbecco's Medium (IMDM)' containing 5°Jo FCS, 5 x 10-5M 2-ME, 2MM L-glutamine,
50 hg/ml streptomycin, and 50 U/ml penicillin (assay medium) containing 2,000 U/ml of
recombinant murine IL-7 . IxN/2b is used as the indicator cell line for routine assessment
Address correspondence to Dr. Linda S. Park, Immunex Corp., 51 University Street, Seattle, Washington
98101 .
1 Abbreviations used in this paper . EGF, epidermal growth factor ; IMDM, Iscove's modified Dulbecco's
medium ; PDGF, platelet-derived growth factor.
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of IL-7 concentrations in sample solutions as opposed to using nonadherent cells from long-
term Whitlock-Witte bone marrow cultures. IL-7 assays were performed essentially as de-
scribed earlier (3). Briefly, IxN/2b cells were pelleted by centrifugation, washed twice,
resuspended in assay medium, and added in 50-Al aliquots (1.2 x 105 cells/ml) to microtiter
plates that contain varying concentrations of IL-7 or test samples. The cells were incubated
for 48 h in a reduced oxygen atmosphere containing 7.5% C02 and 5% 02 and pulsed
during the final 4 h of incubation with 2 ACi/well of [3H]TdR (60-80 Ci/mmol; New En-
gland Nuclear, Boston, MA). The cells were then harvested and the radioactivity was deter-
mined by standard liquid scintillation counting.
Cell Preparations.
￿
All cell lines were grown in RPMI-1640 (Gibco Laboratories, Grand
Island, NY) containing 5-20% FCS and antibiotics, except IxN/2b which were maintained
as described above. Abll.l cells were derived from murine BALB/c bone marrow using Abelson
murine leukemia virus as detailed by Rosenberg and Baltimore (11). The resultant macro-
scopic colonies were plucked and expanded in liquid culture as needed. These cells exhibited
a pre-B cell phenotype (surface p-negative, cytoplasmic W-positive).
Murine B cells (12) and murine bone marrow-derived macrophages (13) were prepared
as previously described. Single cell suspensions were isolated from whole thymus, peripheral
lymph node, and spleen following mechanical dissociation and centrifugation to remove cell
debris. Spleen cell populations were also subjected to hypotonic lysis to remove contaminating
red blood cells.
Cytokines andHormones.
￿
Recombinant human IL-l u and 0 (14), murine granulocyte/mac-
rophage (GM)-CSF (15), and murine IL-4 and human IL-2 (16) were produced and purified
as previously described. Human G-CSF, CSF1, IL-5, and TNFa were constructed as fusion
proteins containing an additional octapeptide at the NH2 terminus, expressed in yeast, and
purified as previously described (17, 18). Human IL-6 was cloned as described elsewhere (8),
expressed in yeast, and partially purified by chromatography on S-Sepharose (Pharmacia
Fine Chemicals, Piscataway, NJ). Escherichia coli-derived human TNF/3 was obtained from
R & D Systems Inc. (Minneapolis, MN). Human TGF/3 was obtained from Collaborative
Research (Bedford, MA). Murine epidermal growth factor (EGF) was obtained from Sigma
Chemical Co. (St. Louis, MO), and human insulin was obtained from Calbiochem-Behring
Corp. (La Jolla, CA).
Cell Surface Analysis.
￿
Expression of cell surface antigens was determined by labeling 5 x
105 cells with a primary antibody followed by labeling with fluorescein-conjugated goat
anti-rat Ig or goat anti-mouse Ig (Tago, Inc., Burlingame, CA). The mAbs used were: anti-
Thy-1, clone T24-31.7 (19); anti-Ly-1, clone 53.73 (20); antiJ11D (21); anti-IL-2R, 7D4, specific
for murine p55 (22); PK136, specific for the NKIA Ag (23); anti-Pgp-1(24); 14.8 (anti-Ly5/220)
(25); BPI (Dr. M. D. Cooper, University of Alabama, Birmingham, AL); anti-Mac-1 (26).
Fluorescein-conjugated goat F(ab')2 anti-murine IgM (W chain specific) was purchased from
Tago, Inc. Fluoresceinated anti-murine K and X were obtained from Fischer Biotech (Or-
angeburg, NY). Labeled cells were analyzed using an EPICS-C flow cytometer (Coulter Elec-
tronics, Hialeah, FL).
Recombinant IL-7 Purification and Radiolabeling.
￿
Murine IL-7 was purified from superna-
tants of COS-7 monkey kidney cells transfected with the murine IL-7 clone 1046B (4) as
previously described (3). After purification, IL-7 concentrations were determined by amino
acid analysis, and activity was measured in the IxN/2b proliferation assay. Purified IL-7 was
radiolabeled using the enzymobead radioiodination reagent (Bio-Rad Laboratories, Rich-
mond, CA) as previously described for murine recombinant GM-CSF (27). Radiolabeled
stocks were stored at 4°C in RPMI-1640 containing 2% BSA, 20 mM Hepes buffer, and
0.2% sodium azide, pH 7,2 (binding medium). Bioactivity was determined in the IXN/2b
assay on samples in which sodium wide had been deleted. The specific activities of radiola-
beled preparations were based on determination of an initial protein concentration by amino
acid analysis, with correction from control experiments to determine protein recovery after
iodination, in which an aliquot of IL-7 was spiked with '251-IL=7 and put through the iodi-
nation protocol with omission of 1251.
BindingAssays andDataAnalysis.
￿
Binding assays were performed by a phthalate oil separa-
tion method (28) as previously described (27) . Nonspecific binding was measured using ei-ther a 500-fold or greater molar excess of unlabeled IL-7 or rabbit serum raised against mu-
rine IL-7 at a concentration that was shown in control experiments to equivalently inhibit
125I-IL-7 binding. In either case unlabeled IL-7 or polyclonal serum was mixed with I25I-IL-
7 before addition of cells.
Association and dissociation kinetic experiments were conducted as previously described
(27) and analyzed with functions that are single or sums of exponential terms as described
elsewhere (29). Curvilinear equilibrium binding data were analyzed using an equation con-
sisting of the sum of two simple Michaelis-Menten terms as previously described (18, 30).
Inhibition data were analyzed with an equation for competitive inhibition between two ligands
for two types ofsites that consists ofthe sum of two simple terms as described elsewhere (18).
Curve fitting was done using R5/1 (Bolt, Beranek and Newman, Boston, MA), a commer-
cially available data processing package running on a Microvax II under the VMS operating
system .
Affinity Crosslinking.
￿
IxN/2b cells (1.5 x 10') were incubated with '251-IL-7 (1 x 10-9 M)
in the presence or absence of unlabeled IL-7 (1 x 10-6 M) for 2 h at 4°C. The cells were
then washed twice in PBS at 4°C and bis-(sulfosuccinimidyl) suberate (BS') was added to
a final concentration of0.1 mg/ml. After 30 min at 25°C the cells were washed and resuspended
in 150 P,1 of PBS117o Triton containing 2 mM PMSF, 10 AM pepstatin A, 10 ,UM leupeptin,
2 mM o-phenanthroline, 2 mM EGTA, 1.25 mM benzamidine, 0.5 mM EDTA, 2 Irg/ml soy-
bean trypsin inhibitor, and 20 Wg/ml E-64 for 5 min at 4'C, centrifuged at 12,000 g for 10
min, and the supernatants were retained.
SDS-PAGE.
￿
Samples were boiled for 3 min in sample buffer (0.06 M Tris-HCI, pH 6.8,
2% SDS, 10ojo glycerol) with or without 5% 2-ME and analyzed on 8% or 10-20% gradient
gels by the procedure of Laemmli (31). Methyl '4C-labeled molecular markers were pur-
chased from Bethesda Research Laboratories (Gaithersburg, MD). After electrophoresis, gels
were stained with Coomasie blue (0.25% in 25% isopropanol, 10% acetic acid), dried, and
exposed to Kodak X-Omat AR film at -70°C.
Results
Cell SurfaceAnalysis ofIxN/26.
￿
The IxN/2b cell line is absolutely dependent upon
exogenous IL-7 for continued growth. To determine the cell surface phenotype of
this line, IxN/2b cells were stained with a variety of mAbs and analyzed using an
EPICS-C flow cytometer. Some of the results are depicted in Fig. 1. The cells ex-
pressed detectable levels ofthe lymphoid precursor antigens, Pgp-1, BP-1, and J11D.
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FIGURE 1.
￿
Cytofluorographic analysis of the B
lineage cell line IxN/26. The surface phenotype
was assessed by immunofluorescence following
incubation with rat or mouse mAbs as the pri-
mary antibodies and FITC-conjugated goat anti-
mouse Ig or rat Ig, as needed, as the secondary
reagent. The cells were incubated for 30 min at
4°C in the indicated primary antibody, washed
3 x in PBS containing 1% BSA, and incubated
another 30 min at 4°C with the secondary re-
agent. Following washing, the cells were analyzed
using an EPICS-C flow cytometer.
2nd Step Jlld
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The IxN/2b cell line is, however, B lineage committed, as it contained a rearranged
It heavy chain anda germline light chain(data not shown) . The cellsexpressed high
levels of class IMHC antigen but did not express detectable levels of class II mole-
cules, consistent with an immature phenotype . Interestingly, the cells expressed sur-
face 14 in the absence of light chain rearrangement and expression . The cells were
negative for cell surface expression of the lineage-specific markers: myeloid lineage
(Mac-1), T cell lineage (Thy-1), B lineage (B220) and natural killer cells (NK1 .1).
Additionally, the cells did not express the Ly-1 marker, the IL-2 receptor (p55), or
the Fc receptor . It would appear therefore that the IxN/2b cell line is an example
of an earlyB cell progenitor that displays aberrant expression of A, chain in the ab-
sence of light chain expression . Given that this cell line was dependent upon IL-7,
we hypothesized that it should express specific receptors for IL-7 . Accordingly, we
began our characterization of the IL-7 receptor using the IxN/2b cell line .
Radiolabeling ofMurine IL-7.
￿
Recombinant murine IL-7 was purified to apparent
homogeneityby previously described methods (3), andiodinatedwith theenzymobead
radioiodination reagent. Fig. 2A shows an autoradiograph of an iodinated murine
IL-7 preparation that migrates as a broad band following SDS-polyacrylamide gel
electrophoresis (averageM r of -25,000) . Radiolabeled preparations consistently dis-
played specific activities in the range of 2-4 x 1015 cpm/mmol (average of 2 .8 ±
0.2 x 1015 from 15 separate iodinations) . Murine IL-7 contains only one tyrosine
residue which is very near the NH2 terminus (amino acid 12), and judging from
the average specific radioactivityobtained, it appears that this residue is beingnearly
quantitatively radiolabeled . In addition, when the biological activities of such prepa-
rations were measured in the IxN/2b proliferation assay they were found to retain
100% of their biological activity (Fig . 2 B) . Given the presence of a single tyrosine
residue as a target forlabeling with 1251, and the full retention of biological activity
following radiolabeling, it is likely that the 1251-labeled IL-7 preparations are rela-
tively homogeneous . In addition, radiolabeled preparations were subjected to gel
filtration chromatographyon a PharmaciaFPLC system using a Superose 12 column
(Pharmacia Fine Chemicals), and it was found that the radiolabeled proteinmigrated
as a single major peak with anM rof 20-30 x 10 3 (data not shown) . No higher mo-
lecular weight aggregates were observed . An identical profile was obtained when
FIGURE 2 .
￿
Characterization of 1251-
IL-7 by SDS-PAGE and proliferative
response of IxN/26 cells . (A) 1251-IL-
7 (specific radioactivity, 2.8 x 10 5
cpm/mmol)was boiled in sample buffer
containing2% SDSand5% 2-ME and
10,000 cpm were applied to a linear
10-20% gradient gel . Electrophoresis
and autoradiography were conducted
as described under Materials and
Methods . (B) IxN/2b cells were cul-
tured in the presence of varying con-
centrations of IL-7 (O) or '25I-IL-7
(") and proliferative response was as-
sayed asdescribedunder Materialsand
Methods ."'I-IL-7 was preincubated with high concentrations of unlabeled IL-7 before chro-
matography, substantiating further that IL-7 does not appear to have a propensity
towards self-association.
Kinetic and Equilibrium Binding Characteristics.
￿
Binding studies with radiolabeled
IL-7 showed that it exhibited relatively rapid, specific, andsaturablebindingto IxN/2b
cells at both 370 and 4°C. Fig. 3 illustrates IL-7 association kinetics, which shows
that both at 40C (Fig. 3 A) and 370C (Fig. 3 B) the final equilibrium amount of
ligand bound to cells and the approach to equilibrium are dependent upon the ini-
tial concentration of1211-IL-7 in the medium . The time required to reach equilib-
rium at 37°C is much shorter (<15 min) than the time required at 40C (tit h). The
data depicted in Fig. 3, A and B, were analyzed both with an exponential function
describing time-dependent binding to a single class of receptors, and with a func-
tion containing the sum of two exponential terms which describes time-dependent
binding to two classes of receptor sites. Both models produced very similar fitted
curves. The curves shown passing through the data in Fig. 3, A and B, were gener-
ated using aone-site model. Fig. 3 C shows plots of the pseudo-first-order associa-
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FIGURE 3. Association kinetics of 125I-IL-7
with IxN/2b cells. IxN/2b cells (1.33 x 107
cells/ml) were incubated with 8.1 x 10-'° M(O),
3.3 x 10-10 M (EI), or 9.0 x 10-11 M (A)
1251-IL-7 at 40C (A) or 9.3 x 10-10 M (0), 3.5
x 10-10 M (0) or 1.0 x 10-10 M (A) "I-IL-7
at 370C (B). At the timesindicated, aliquots were
removed and assayed for binding as described
underMaterials and Methods. Alldata were cor-
rected fornonspecific bindingandthecontinuous
curves passing through the data were calculated
from thebest-fit parametervalues usingasimple
exponential term as described under Materials
and Methods. Infinite time binding (mole-
cules/cell) andt pseudo first-order association rate
constants(M- min-1)calculated for each curve
were, respectively, A (0) 496 f 16 and 2.8 ±
0.3 x 10-~; ([]) 302 t 15 and 2.4 ± 0.4 x 10-2;
(A) 123 t 9 and 1.9 f 0.3 x 10-2 and B (0)
367 t 9and0.28 t 0.02;(p) 194 f 8 and 0,14
± 0.01; (A)55 t 6and0.13 ± 0.03. (C)Pseudo
first-order association rate constants calculated
9
￿
15
￿
from thecurves in A (0) and B (A) vs. the molar
Time ( min)
￿
concentration [CJ of "5I-IL-7 initially present
in themedium. Theline passingthroughthe data
3
￿
o
￿
was generatedby linearleastsquares analysis. The
pseudo first-order association rate constants (k)
O
￿
are related to the association rate constant k1
2 O
￿
(second-order) andthedissociation rate constant x
￿
k-1 (first-order) by the equation k = k1 [C] +
Y
￿
k_ 1 wheretheforward and reverse rate constants
of 1251-IL-7 can be determined, respectively,
from theslopeandordinate interceptof thefitted
lines.
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tion rate constants determined from the curves in Fig. 3, A and B, relative to the
initial concentration of "'I-IL-7 in the medium. The forward and reverse rate con-
stant of "5I-IL-7 can be determined respectively from the slope and ordinate in-
tercept ofthe fitted lines. From the average of two separate experiments at each tem-
perature, the values obtained for 37 and 4°C were, respectively, 1.7 t 0.2 x 108
and 1.4 t 0.2 x 107 M-' min-' for the forward rate constants and 0.11 t 0.01 and
1.6 t 0.3 x 10-2 min-1 for the reverse rate constants. These data show that both
the association and dissociation rates at 37°C are -10-fold higher than those at 4°C.
Due to this 10-fold difference in both rate constants, the binding affinity of radiola-
beled IL-7, estimated from the ratio of these two constants, would nonetheless be
predicted to be similar at 4°C and 37°C (8.7 x 108 M-1 and 1.5 x 109 M-1 , respec-
tively).
Fig. 4 illustrates typical equilibrium binding data for 121I_IL-7 to IxN/2b cells
at both 4°C (Fig. 4 A) and 37°C (Fig. 4 B). Scatchard analysis of the data yielded
acurvilinear plot at both temperatures. The curves passingthrough the points have
been fit with an equation consisting of the sum oftwo Michaelis-Menten terms (30) .
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FIGURE 4.
￿
Equilibrium bind-
ingof 1251-IL-7 to IxN/2b cells.
Various concentrations of 125I-
IL-7 were incubated with IxN/
2b cells(3 .3 x 107 cells/ml) for
2 h at 4°C (A) or with IxN/26
cells (1.33 x 107cells/ml) for30
min at 37°C (B). Binding was
assayed as described under
MaterialsandMethodsandall
data were corrected for non-
specific binding. The insets
show Scatchardrepresentations
of specific binding replotted
from A andB. Curvefitting was
done as described in Materials
and Methods.PARK ET AL.
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From the average of nine bindingexperiments at 4°C, IL-7 binding to IxN/2b cells
displayed a high affinity component with an apparent Ka of 1.2 t 0.1 x 101° M-1
and 325 t 55 specific binding sites per cell and a low affinity component with an
apparent Ka of 3.9 t 0.5 x 108 M-I with 1,983 t 226 specific binding sites per
cell. Equilibrium binding parameters measured at 37 °C were very similar. From
the average of 11 binding experiments at 37°C a high affinity component with an
apparent Ka of 8.8 t 0.6 x 109 M-t and 543 t 68 specific binding sites per cell
and a low affinity component with an apparent Ka of 4.8 t 0.6 x 108 M-1 with
1,963 t 148 specific binding sites per cell were obtained.
Direct measurement ofthebindingaffinity ofunlabeled IL-7 by inhibition ofbinding
of 1251-IL-7 to IxN/2b cells at 37°C is shown in Fig. 5. We found the data could
notbe adequately analyzed using a single-site competitiveinhibition equation. How-
ever, when the data were fit with an equation for competitive inhibition between
two ligands for two types of sites, the curve shown in Fig. 5 was obtained, which
exhibits an excellent fit to the experimental points. From an average of three inhibi-
tion experiments we found the high affinity component displayed a KI value of 2.7
t 0.5 x 101° M-I with a maximal level of inhibition of 37.5 t 2.9% and the low
affinity component a K1 value of 4.1 t 1.5 x 108 M-I with a maximal level of inhi-
bition of60.9 t 2.3. These values arevery similarto those obtained by direct binding
with 1251_IL-7 and substantiate the existence of two classes of binding sites for IL-
7 on IxN/2b cells.
Thereareseveral possible reasons fortheappearance of curvilinear Scatchard plots,
including thepresence of two independent bindingsites with different affinities, the
presence of negative cooperative interactions, or both. As firstdescribedin the model
of Demeyts et al. (32), a diagnostic test for the presence of negative cooperativity
is an accelerated dissociation rate ofradiolabeled ligand when measured in the pres-
ence of an excess of unlabeled ligand. Fig. 6 shows the dissociation of 1251-IL-7 from
IxN/2b cells at 4°C (Fig. 6 A) and 37°C (Fig. 6 B). At both temperatures, dissocia-
tion was measured in medium alone, where afraction of the receptors are occupied,
and in the presence of 8 x 10 -8 M unlabeled IL-7, where most of the receptors are
occupied. Several features of the data can be observed. First, the dissociation rate
at 4°C with or without IL-7 in the mediawasvery slow. In addition, thedata could
FIGURE 5.
￿
Inhibition of 1251-IL-7 binding to
IxN/2b cells by unlabeled IL-7. IxN/2b cells (2
x 107 cells/ml) were incubated with 1251-IL-7
(3.7 x 10-11 M) and varying concentrations of
unlabeled IL-7. Incubation was for 30 min at
37°C andbindingwasassayed as describedunder
Materials and Methods. The continuous curve
passing through the data was calculated from a
two-site competitive inhibition equation using K
values for I sI-IL-7 of 9.2 x 109 M-1 (high
affinity) and 4.2 x 108 M-1 (low affinity). All
data were corrected fornonspecific bindingmea-
sured in thepresence of5 x 10-s unlabeled IL-7.1080
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be suitably analyzed with an exponential function that describes asimple first-order
process to produce the curves passing through the data in Fig. 6A. In contrast, at
37°C a distinct biphasic kinetic pattern was observed that consisted of a very rapid
initial dissociation rate followed by an extremely slow component that appears es-
sentially irreversible. In the presence ofunlabeled IL-7 in the media, the initial dis-
sociation rates at both 37 and 4°C were significantly enhanced (see legend to Fig.
6) . In addition, at 37°C the irreversible component of dissociation was eliminated,
with the amount of specifically bound 1251-IL-7 dropping to background levels
(nonspecific binding) within 30 min. These data indicate that the rate of dissocia-
tion of IL-7 from IxN/2b cells is sensitive to receptor occupancy, and suggest that
IL-7 receptors on IxN/2b cellsexhibitnegative cooperative behavior. Such behavior
would result from decreasing affinity of IL-7 binding with increasing receptor oc-
cupancy and would predict that curvilinear binding curves might be obtained from
equilibrium binding experiments.
The reason for the essentially irreversible component in the dissociation curves
at 37°C is unknown, but may be involved in the mechanism by which IL-7 is able
to transduce abiological signal at low receptor occupancy. Controlexperiments showed
that this irreversibly bound 1211-IL-7 was still on the cell surface even 90 min after
initiation ofdissociation since essentially all of it could be released by alowpH wash
(data not shown). It is also apparent from these experiments that the initial rate
of dissociation at 37°C is much more rapid than at 4°C, which supports conclusions
reached from association kinetic experiments.
SpecificityandCellularDistribution ofIL-7 Receptors.
￿
The specificity of murine IL-7
was assessed by testing a number of purified cytokines, as displayed in Table I, for
their ability to compete with 1251-IL-7 for binding to its receptor on IxN/2b cells.
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FIGURE 6.
￿
Dissociation kinetics of 121j IL-7 from
IxN/26 cells. IxN/26 cells (1.33 x 10' cells/ml) were
incubated with 1251-IL-7 (4.0 x 10-I° M) for 2 h at
4°C. Thecells were then split into twoequalaliquots,
harvestedby centrifugation, and resuspended in ei-
ther bindingmedium alone(O)or bindingmedium
containing 8 x 10-e M unlabeled IL-7 ("). The
cells were maintained at either 4°C(A)or 37°C (B)
and aliquots were removed at various times andas-
sayed for bindingas describedunderMaterialsand
Methods. The concentration of 121I-IL-7 present
during dissociation was <5.0 x 10-12 M. Data ob-
tained at 4°C (A)were analyzed with an exponential
function that describesa simple first-order process.
Dissociation rate constants calculated were: (O) 1.5
t 0.2 x 10-3 min-' ; and (") 3.1 t 0.2 x 10-3
min-' . Data obtained at 37°C (B) were analyzed
with an equation that wasthe sumof an exponential
function andaconstant, whichdescribed thebiphasic
kinetic pattern consisting of arapid initial dissocia-
tion rate followed by a slow component. Dissocia-
tion rate constants fortheinitial raid rate were cal-
culated to be: (O)8.5 t 1.6 x 10- min-I ; and(")
0.20 ± 0.03 min-
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TABLE I
Speceficity of 1151-IL-7 Binding to RN/2b Cells
Inhibitor
￿
"'I-IL-7 bound'
molecules/cell
None
￿
380 t 9
MuIL-7
￿
45 +_ 1
HuIL-lcr
￿
378 + 9
HuIL-10
￿
384 f 1
HuIL-2
￿
389 + 4
MuIL-4
￿
396 + 7
HuIL-5
￿
379 t 13
HuIL-6
￿
385 t 9
MuGM-CSF
￿
400 f 8
HuG-CSF
￿
396 t 15
HuCSF-1
￿
384 + 3
HuTGF-#
￿
405 t 8
HuTNF-a
￿
400 + 12
HuTNF-/3
￿
371 ± 25
MuINF-.y ￿382 t 4
Hu Insulin
￿
334 t 2
Mu EGF
￿
335 f 11
IxN/2b cells were incubated for 30 min at 37°C with 1211-IL-7 and unlabeled
proteins as indicated at a200-fold or greater molar excess. Binding wasassayed
as described under Materials and Methods.
When present in concentrations that were at a 200-fold or greater molar excess as
compared with 1251-IL-7, none of the other molecules exhibited any significant ca-
pacity to compete.
The cellular distribution of murine IL-7 receptors was also examined on a variety
of primary cells and in vitro cell lines. As shown in Table II, IL-7 receptors were
variably expressed on cells of both lymphoid and myelomonocytic origins. For all
cell types shown in Table II, complete binding curves were done over a range of
1251-IL-7 concentrations and receptor numbers per cell were generated by Scatchard
analysis of the data. In all cases, 1251-IL-7 binding generated curvilinear Scatchard
plots, although the ratio of high to low affinity sites and the exact affinity constants
obtained varied somewhat. Due to the fact that it is necessary to average several
complete sets of binding data to obtain accurate binding constants from the high
and low affinity portions of curvilinear Scatchard plots, we have reported only the
total specific binding sites percell in Table II. Not unexpectedly, all pre- and pro-B
cell lines tested expressed significant levels of IL-7 receptors. In contrast, three B
cell lines with a more mature phenotype as well as purified primary mature B cells
did not express detectable levels of IL-7 receptor. Murine thymocytes, as well as
a number of cell lines of the T cell lineage also expressed IL-7 receptors. Although
most cell lines of myelomonocytic origin did not express detectable IL-7 receptors,
quite surprisingly, bone marrow-derived macrophages, as well as the macrophage
tumor line PU5-1.8, displayed significant levels of IL-7 receptor. In addition, the
receptor was expressed on a varietyof primary tissue sources including bone marrow,
lymph node, and spleen at relatively low levels.1082
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TABLE II
Distribution of Murine IL-7 Receptors
Binding experiments were conducted as described in the legend to Fig. 4.
Molecules bound per cell were determined by Scatchard analysis of complete
sets of binding data and represent total sites per cell . The limit of detection is
defined as 20 molecules bound per cell.
Affinity Crosslinkin- o
￿
Themolecular structureofthe IL-7 receptor on IxN/2b cells
was next examined by affinity crosslinking. Cells were incubated with radiolabeled
IL-7 in the presence or absence ofunlabeled IL-7, crosslinked with thewater-soluble
bifunctional reagent BS', and extracted with PBS/1% Triton containing a cocktail
of protease inhibitors. The solublefractionswere then analyzed by SDS-PAGE under
both reducing (Fig. 7, lanes a-c) and nonreducing (Fig. 7, lanes d-,t) conditions.
Two major crosslinked bands were observed under both conditions (Fig. 7, lanes
b ande). Control experiments showed that no crosslinked species were found in the
Lymph node cells
Spleen cells
Thymocytes
B10 and B6/C3H
CBA/N and B6
CBA/N and B6
860 t 40
640 f 20
330 ± 10
Cell lines
IxN/26 IL-7-dependent pre-B 2,510 t 190
Abl 1 .1 Pre-B 12,200
70Z/3 Pre-B lymphocyte 4,600
NFS-5 C-1 Pre-B lymphoblast 6,100
NFS-25 C-3 Pre-B lymphoblast 6,800
NFS-70 C-10 Pro-B lymphoblast 9,900
RAW 8.1 Early B lymphoma 1,900
ABE-8.1/2 Pre-B lymphoma 4,700
BCL-1 B cell lymphoma <20
NS1 Myeloma <20
8.653 Myeloma <20
CTLL Cytotoxic T cell <20
HT-2 Helper T cell <20
EL-4 T lymphoma <20
YAC-1 T lymphoma 2,530
LBRM-33 T lymphoma <20
LBRM-33-1A5 T lymphoma 3,400
LBRM-33-5A4 T lymphoma 1,600 t 400
LSTRA T-lymphocytc leukemia 1,100 t 100
32D Mast cell <20
P815 Mastocytoma <20
WEHI-3 Myelomonocytic <20
FDCP-2 Myeloid <20
P388DI Macrophage tumor <20
J774 Macrophage tumor <20
PU5-1 .8 Macrophage tumor 8,300 t 4,900
Designation Characteristics IL-7 bound'
molecules/cell
Primary cells
Bone marrow BALB/c 360
BM macrophage C3H 3,900
B cells C57BL/6 <20PARK ET AL .
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FIGURE 7 .
￿
Characterization ofIL-7 receptor
IA I) crosslinking . IxN/2b cells (1.5 x 10 )
were incubated with 1251-IL-7 (1 x 10-9M) both
in the absence (lanes a, b, d, e) andpresence(lanes
c,f) ofunlabeled IL-7 (1 x 10-6M) . Incubation
was for 2 h at 40Cand cells were then harvested,
washed, crosslinked, and extracted as described
under MaterialsandMethods . Lanes aanddde-
pict control samples in which all procedures were
conducted except for addition of crosslinker. Ali-
quots corresponding to 2 x 106 cells were boiled
in sample buffer containing2% SDS either with
(lanes a-c) or without 5To 2-ME (lanes d-f)and
subjected to electrophoresis on an 80 10 polyacryl-
amide gel . M r values for crosslinked bands are
determined by comparing R, values to a stan-
dard curve generated by a linear least squares fit
of the Rr values of the 14C-standards .
absence ofcrosslinker (lanes a and d) or in samples containing excess unlabeled IL-7
(lanes c andf. From multiple crosslinking experiments the average relative molec-
ular mass for the two species was calculated to be 186,300 t 4,300 and 100,000 t
1,300 underreducing conditions and 184,000 t 2,100 and 103,500 t 1,000 under
nonreducing conditions . After subtraction of the molecular weight of IL-7 (25,000
Mr), the crosslinked species would correspond to membrane proteins ofM r 161,300
and 75,000 under reducing conditions andM r 159,100 and 78,500 under non-
reducing conditions . The diffuse nature of the crosslinked species and the appear-
ance of two apparently distinct bands within the lower molecular weight band are
likely due to variable levels of glycosylation on the receptor, IL-7 itself (see Fig. 2)
oracombination ofboth. We cannot exclude the possibility, however, that these two
bands represent crosslinking of IL-7 to nonidentical protein species . Interestingly,
the larger receptor species has a molecular weight almost exactly twice that of the
smaller receptor species, raisingthe possibility that itmay represent a receptor dimer.
It does not appear that the larger species is due to disulfide-linked subunits, since
an almost identical crosslinking pattern is obtained under reducing and nonreducing
conditions . In addition, control experiments in which crosslinked cells were extracted
in PBS/1% Triton in the complete absence ofany protease inhibitors revealed that
the relative intensities of the two crosslinked bands were totally unchanged, sug-
gesting that the lowermolecular weight species is notaproteolyticdegradation product
of the larger species (data not shown) . If the larger crosslinked species was due to
the presence of receptor dimers, it was possible that the relative abundance of this
species might be altered when crosslinking experiments were performed at varying
IL-7 concentrations . We found, however, that the relative intensities ofthe high and
low molecular weight speciesremained constant when crosslinking experimentswere1084
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performed with IL-7 concentrations rangingfrom 1 x 10-'° Mto 3 x 10-9 M (data
not shown). In addition, over this range, the calculated molecular weights of the
crosslinked bands did notchange, norwas there any appearance ofhigher molecular
weight aggregates.
Discussion
We report here the isolation ofan IL-7-dependent cell line, designated IxN/2b,which
has been used as the basis for a consistent and sensitive bioassay for IL-7 . The bio-
assay system originally used for the detection and isolation of murine IL-7 used
freshly isolated B cell progenitors from long-termWhitlock-Witte bone marrow cul-
tures. We now routinely use the IxN/2b cells as target cells in IL-7 bioassays. On
aper-cell basis, theIxN/2b cell line incorporates approximately four times as much
thymidine as pre-B cells grown in Whitlock-Witte bone marrow cultures. The cells
are quite sensitive to stimulation with IL-7, and under the conditions of the assay
they demonstrate ahalf-maximal stimulation response at -0.05 ng/ml ofIL-7, which
translates to a half-maximal concentration of 3.3 pM.
Since the IxN/2b cell line is absolutely dependent on IL-7 for growth and via-
bility, it also provided an ideal model in which to studyputative cell surfacereceptors
for IL-7. Although murine IL-7 contains only a single tyrosine residue very near
the NH2 terminus of the molecule, we found this residue could be almost quantita-
tively radiolabeled with '251 to produce a homogeneous radiolabeled preparation
that retained full biological activity in an IxN/2b proliferationassay. We determined
that ' 251-IL-7 bound rapidly to IxN/2b cells at both 4° and 37°C, although the as-
sociation rate was -10 times faster at 37°C, reaching equilibrium within 15 min.
Equilibrium binding studies revealed that '251-IL-7 binding produced curvilinear
Scatchard plots at both temperatures, with a high affinity component having a Ka
of -1 x 10'° M-' and a low affinity component with a Ka of -4 x 108 M-' . Of
the 2,000-2,500 total IL-7 binding sites expressed per cell, -15-20% were of the
high affinity type. Experiments designed to measure the affinity of unlabeled IL-7
by its ability to inhibit the binding of 1251-IL-7 to its receptor also produced data
consistent with the existence of two classes of IL-7 receptors on IxN/2b cells, with
affinities similar to those obtained by direct 1251-IL-7 binding.
Some evidence concerning the possible molecular nature of two classes of IL-7
receptorswas provided by dissociation kinetics and affinity crosslinking experiments.
There are several possible reasons for the appearance of curvilinear Scatchard plots
including (a)the presence oftwo or more noninteracting binding siteswith unchanging
anddissimilar affinities; (b)theexistenceof multiple "affinity states" ofasingle receptor
species, as a result, forinstance, of variable phosphorylation or other modifications;
and (c) the presence of negative cooperativity, such that the affinity of the overall
receptor population decreases with increasing occupancy of receptors. Curvilinear
Scatchard plots can also be caused artifactually by nonhomogeneous radiolabeled
ligand preparations containing species displaying varying affinity or kinetic constants,
or by thetendency ofaligand to aggregateat high concentrations to produce dimers
or multimers possessing decreased receptor binding. A diagnostic test to distinguish
between multiple noninteracting receptor species andreceptor populationsdisplaying
negative cooperative behavior was first described by Demeyts et al. (32), in whichPARK ET AL.
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the dissociation rate of radiolabeled ligand is measured both in the presence and
absenceof an excess of unlabeled ligand. Ifnegative cooperativity amongthereceptors
exists, filling of receptors with unlabeled ligand may decrease the overall affinity of
the receptor population and can potentially accelerate the rate of radioligand dis-
sociation. When this experiment was performed with IxN/2b cells, we found that
the dissociation rate of 1251-IL-7 was markedly increased by the presence of unla-
beled IL-7 at both 37° and 4°C. One possible explanation for this behavior is that
the IL-7 receptor contains abinding subunit that can form noncovalently associated
dimers in the membrane. Curvilinear Scatchard plots would be expected to result
if the dimer species was capable of binding IL-7 with a higher affinity than the
monomer. In addition, if the monomer and dimer species were present in an equi-
librium that could be shifted towards the presence of low affinity monomers as the
IL-7 concentration increased, apparent negative cooperative behavior could be ob-
served. In itsmost strict definition, negative cooperativity refers to asystem in which
acontinuous change in affinity ofa receptor population is induced by ligand binding.
Although the dissociation kinetics experiments can be operationally defined as ex-
hibiting negative cooperative behavior, we do not yet have sufficient information
to infer what molecular mechanisms are producing it.
Additional evidence that the IL-7 receptor may exist, at least partially, as a
non-disulfide-linked dimer, was provided by affinity crosslinking experiments. Under
both reducing and nonreducing conditions the major crosslinked species observed
had amolecularmass of 100-104 kD, corresponding to a receptor size of 75-79 kD.
In addition, aless intense higher molecularweight crosslinked species was also seen
underboth reducing and nonreducing conditions with amolecular mass of 184-187
kD, corresponding to a receptor size of 159-162 kD. The larger species therefore
has a molecularmass slightly higher than twice that ofthe smallerspecies, suggesting
that it may be a receptor dimer crosslinked to one (or possibly two) molecules of
1251-IL-7. We cannot rule out at this point that the 184-187-kD form is due to cross-
linking of 1251-IL-7 to a receptor species distinct from that producing the 100-104-
kD form, or even due to crosslinking of 1251-IL-7 to a complex of the 75-79-kD pro-
tein plus an additional subunit. It appears unlikely, however, from experiments done
in the presence and absence ofprotease inhibitors, that the smallerspecies is a pro-
teolytic degradation product of the larger form.
In recent years, evidence for dimerization of receptor subunits has been reported
for several growth factor receptor systems. The EGF receptor is perhaps the best
example. Binding experiments with 1251-EGF, which is a monomeric ligand, fre-
quently generate curvilinear Scatchard plots (33). It has been shown that the EGF
receptor can exist in both monomeric and dimeric states and that EGF binds to
dimeric receptors with higher affinity than it does to monomeric receptors. Further-
more, the binding of EGF has been shown to induce receptor dimerization, which
results in an increased tyrosine protein kinase activity compared with that observed
for monomeric receptors (34-37). Recently, evidence has also been presented that
high affinity bindingof platelet-derived growth factor (PDGF), adimericligand con-
sisting of several isoforms, requires association of two different receptor subunits,
and can in fact induce receptor dimerization (38-40). As with the EGF receptor,
this dimerization has been correlated with an activation of the protein tyrosine ki-
nase activity of the PDGF receptor (39). Even the insulin receptor, which consists1086
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of a disulfide-linked a282 heterotetramer, has been shown to bind 1251-insulin with
much lower affinity when dissociated into functional u/a heterodimers (41, 42).
While dissociation kinetics and affinity crosslinking experiments with 1251-IL-7
suggest that the IL-7 receptor may exist in both monomeric and dimeric forms, we
have no evidence that IL-7 itself is capable of inducing receptor dimerization. We
have seen no evidence from gel filtration experiments that IL-7 has a propensity
to form dimeric or oligomeric species in solution. In addition, crosslinking experi-
ments done with varying concentrations of 1251-IL-7 did not show an alteration in
the amount of the higher molecular weight crosslinked species. A more definitive
assessment of the role that receptor dimerization may play in generating the ob-
served bindingcharacteristics of the IL-7 receptor, and whether additional hetero-
geneitymay also exist in the interaction of IL-7 with its receptor bindingprotein(s),
will require further analysis.
In addition to characterization of the IL-7 receptor on the pre-B cell line IxN/2b,
we also examined a variety of primary cells and in vitro cell lines for their ability
to express IL-7 receptors. Although the levels of expression ranged from a few hun-
dred to a few thousand receptors per cell, all cell types that were found to bind
1251-IL-7 exhibited curvilinear Scatchard plots with high and low affinity binding
constants in the same range as those calculated for IxN/2b cells. Not unexpectedly,
all pre- and pro-B cell lines examined displayed relatively abundant levels of IL-7
receptors. However, three B cell lines ofamore mature phenotype, as well as purified
primary mature B cells failed to bind detectable levels of 1251-IL-7 . Although it is
possible that mature B cells express IL-7 receptors at levels below the assay sensi-
tivity, this receptor display correlates with the known biological activities of IL-7
on the B cell lineage, where no effects of IL-7 on mature B cells have yet been ob-
served (3, 43). In addition, the IL-7 receptor was found to be expressed at low levels
on murine thymocytes andon some, but not all, Tlineage cell linestested. Although
IL-7 was originally isolated as a pre-B cell growth factor, it has subsequently been
found to stimulate both T cell progenitors (5-7) and mature T cells as well (8, 9).
Most surprisingly, IL-7 receptor was found to be expressed at relatively high levels
on bone marrow-derived macrophages, as well as PU5-1.8, a macrophage tumor
cell line. Although several other cell lines of myelomonocytic origin were negative,
the presence of IL-7 receptors on two macrophage populations suggests that IL-7
mayhave as yet unexplored effects on cells outside the lymphoid compartment. This
would not be totally unexpected given our prior observations regarding the effects
of IL-7 on megakaryocyte differentiation (44).
Characterization ofIL-7 receptors on different cell lineages, as well as furtherex-
ploration into the role that dimerization ofthe IL-7 receptor may play in IL-7 signal
transduction, should provide future insights into the mechanism and specificity of
IL-7 action.
Summary
A murine cell line (IxN/2b) absolutely dependent upon exogenous IL-7 for con-
tinued growth has been obtained that expresses lymphoid precursor andclass I MHC
antigens and also contains a rearranged pt heavy chain. This cell line hasbeen used
to define thebindingand structural characteristics ofthe murine IL-7 receptor using
1251-labeled recombinant murine IL-7 . 1251-IL-7 binding to IxN/2b cell was rapidPARK ET AL.
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and saturable at both 4° and 37 °C. Equilibrium binding studies produced curvilinear
Scatchard plots at both temperatures with high and low affinity K,, values of -I x
101° M'1 and 4 x 108 M-1 , respectively, and a total of 2,000-2,500 IL-7 binding
sites expressed per cell. Experiments measuring inhibition of binding of 1251-IL-7
by unlabeled IL-7 also produced data consistent with the existence of two classes
ofIL-7 receptors. Evidence concerning the possible molecular nature of two classes
of IL-7 receptors was provided by dissociation kinetics and affinity crosslinking ex-
periments. The dissociation rate of 1251-IL-7 was markedly increased when mea-
sured in the presence of unlabeled IL-7 at both 37 ° and 4°C, which is diagnostic
of a receptor population displayingnegative cooperativity. Crosslinking studies showed
that under both reducing and nonreducing conditions, the major crosslinked spe-
cies observed corresponded to a receptor size of 75-79 kD while a less intense higher
molecular mass crosslinked species was also seen which corresponded to a receptor
size approximately twice as large (159-162 kD). Both types of experiments suggest
that the IL-7 receptor may form noncovalently associateddimers in the membrane.
The IL-7 receptor was expressed on pre-B cells, but not detected on several mature
B cell lines or primary mature B cells. It was also expressed on murine thymocytes,
some T lineage cell lines, and on bone marrow-derived macrophage. All cells binding
1251-IL-7 exhibited curvilinear Scatchard plots. No cytokines or growth factors
tested were able to inhibit binding of 1251-IL-7 to its receptor. These results define
the initial binding and structural characteristics, and the cellular distribution, of
the murine IL-7 receptor.
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